share_log

HC Wainwright & Co. Reinstates Buy on Aldeyra Therapeutics, Announces $10 Price Target

HC Wainwright & Co. Reinstates Buy on Aldeyra Therapeutics, Announces $10 Price Target

HC Wainwright & Co.恢復對Aldeyra Therapeutics的買入,宣佈10美元的目標股價
Moomoo 24/7 ·  04/02 08:43

HC Wainwright & Co. analyst Matthew Caufield reinstates Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy and announces $10 price target.

HC Wainwright & Co. 分析師馬修·考菲爾德以買入重啓了Aldeyra Therapeutics(納斯達克股票代碼:ALDX),並宣佈了10美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論